Half-Life Calculator
Calculate pharmacokinetic and radioactive decay half-lives with professional accuracy and clinical applications
Half-Life Calculation
Starting concentration
Concentration at time t
Time between measurements
Add any relevant notes about this calculation
Half-Life Information
Half-life is the time required for a quantity to reduce to half its initial value. It's fundamental in pharmacokinetics, radioactive decay, and biological processes.
Key Applications:
Kinetic Models:
• First-order: Constant fraction eliminated
• Zero-order: Constant amount eliminated
• Multi-compartment: Complex distribution
Clinical Relevance:
• Dosing frequency: typically every 1-2 half-lives
• Steady-state: reached after 5 half-lives
• Drug accumulation: depends on dosing interval
• Elimination: 97% eliminated after 5 half-lives
Half-Life Application Scenarios
Reference guide for half-life applications across pharmacokinetics, radioactive decay, and biological processes
Elimination Half-Life
Drug elimination from systemic circulation
Typical Range: 0.5-72 hours
Clinical Importance: Determines dosing frequency and steady-state timing
Influencing Factors:
Applications:
• Dosing regimen design
• Drug interaction assessment
• Therapeutic monitoring
Examples:
Substance | Half-Life | Notes |
---|---|---|
Digoxin | 36 hours | Renal elimination, monitor in kidney disease |
Warfarin | 40 hours | Hepatic metabolism, multiple drug interactions |
Phenytoin | 22 hours | Saturable metabolism, non-linear kinetics |
Absorption Half-Life
Drug absorption from administration site
Typical Range: 0.1-8 hours
Clinical Importance: Affects onset of action and peak plasma concentrations
Influencing Factors:
Applications:
• Bioequivalence studies
• Modified-release formulations
• Onset prediction
Examples:
Substance | Half-Life | Notes |
---|---|---|
Immediate-release tablets | 0.5 hours | Rapid dissolution and absorption |
Extended-release formulations | 4 hours | Controlled drug release |
Transdermal patches | 12 hours | Sustained absorption through skin |
Distribution Half-Life
Drug distribution to tissues
Typical Range: 0.1-2 hours
Clinical Importance: Determines time to equilibrium between plasma and tissues
Influencing Factors:
Applications:
• Loading dose calculations
• Tissue penetration studies
• CNS drug development
Examples:
Substance | Half-Life | Notes |
---|---|---|
Propofol | 0.25 hours | Rapid redistribution to fat tissue |
Thiopental | 0.5 hours | Quick onset, short duration due to redistribution |
Lidocaine | 0.17 hours | Rapid tissue distribution |
Medical Isotopes
Radiopharmaceuticals for imaging and therapy
Typical Range: Minutes to years
Clinical Importance: Radiation safety and imaging protocol design
Influencing Factors:
Applications:
• Nuclear medicine
• Radiation therapy
• Medical imaging
• Radiation safety
Examples:
Substance | Half-Life | Notes |
---|---|---|
Technetium-99m | 6.01 hours | Most common imaging isotope |
Iodine-131 | 192 hours | Thyroid therapy and imaging |
Fluorine-18 | 1.83 hours | PET imaging, short half-life |
Therapeutic Isotopes
Radioactive isotopes for cancer treatment
Typical Range: Hours to months
Clinical Importance: Treatment planning and radiation protection
Influencing Factors:
Applications:
• Targeted radiotherapy
• Brachytherapy
• Systemic radiation therapy
Examples:
Substance | Half-Life | Notes |
---|---|---|
Yttrium-90 | 64.1 hours | Beta emitter for liver cancer |
Lutetium-177 | 160.4 hours | Neuroendocrine tumor therapy |
Radium-223 | 275.2 hours | Bone metastases treatment |
Diagnostic Isotopes
Short-lived isotopes for imaging
Typical Range: Minutes to days
Clinical Importance: Image quality and patient radiation exposure
Influencing Factors:
Applications:
• SPECT imaging
• PET imaging
• Cardiac studies
• Brain imaging
Examples:
Substance | Half-Life | Notes |
---|---|---|
Carbon-11 | 0.34 hours | Very short half-life, on-site production |
Gallium-68 | 1.13 hours | Generator-produced, PET imaging |
Indium-111 | 67.3 hours | White blood cell labeling |
Protein Degradation
Cellular protein turnover
Typical Range: Minutes to weeks
Clinical Importance: Understanding cellular metabolism and disease processes
Influencing Factors:
Applications:
• Drug target validation
• Biomarker development
• Disease mechanism studies
Examples:
Substance | Half-Life | Notes |
---|---|---|
Insulin | 4 minutes | Rapid turnover, tight glucose control |
Albumin | 504 hours | Long-lived plasma protein |
Hemoglobin | 2880 hours | RBC lifespan marker |
Enzyme Kinetics
Enzyme inactivation and turnover
Typical Range: Minutes to hours
Clinical Importance: Metabolic pathway regulation and drug interactions
Influencing Factors:
Applications:
• Drug metabolism studies
• Enzyme replacement therapy
• Metabolic disorders
Examples:
Substance | Half-Life | Notes |
---|---|---|
CYP3A4 | 24 hours | Major drug metabolizing enzyme |
Acetylcholinesterase | 168 hours | Neurotransmitter breakdown |
Factor VIII | 12 hours | Coagulation factor, hemophilia treatment |
Cellular Markers
Biomarker turnover in biological systems
Typical Range: Hours to days
Clinical Importance: Disease monitoring and therapeutic response assessment
Influencing Factors:
Applications:
• Clinical diagnostics
• Treatment monitoring
• Prognosis assessment
Examples:
Substance | Half-Life | Notes |
---|---|---|
Troponin I | 6 hours | Cardiac injury marker |
PSA | 66 hours | Prostate cancer monitoring |
HbA1c | 2160 hours | Long-term glucose control |
Pollutant Degradation
Environmental contaminant breakdown
Typical Range: Days to years
Clinical Importance: Environmental risk assessment and remediation planning
Influencing Factors:
Applications:
• Environmental monitoring
• Pollution control
• Risk assessment
• Remediation design
Examples:
Substance | Half-Life | Notes |
---|---|---|
DDT | 8760 hours | Persistent organochlorine pesticide |
Atrazine | 1440 hours | Herbicide, groundwater contamination |
PCBs | 87600 hours | Industrial pollutants, bioaccumulation |
Pharmaceutical Residues
Drug residues in environmental systems
Typical Range: Hours to months
Clinical Importance: Environmental pharmaceutical contamination assessment
Influencing Factors:
Applications:
• Water treatment
• Environmental impact assessment
• Regulatory compliance
Examples:
Substance | Half-Life | Notes |
---|---|---|
Antibiotics | 168 hours | Resistance development concern |
Hormones | 72 hours | Endocrine disruption potential |
Analgesics | 48 hours | Common in wastewater |